Novel Drug Lowers Stubbornly High BP in Phase 3 Trial ...Middle East

Lorundrostat, an aldosterone synthase inhibitor, effectively treated uncontrolled hypertension in Launch-HTN, researchers reported in JAMA. Medscape Medical News

Hence then, the article about novel drug lowers stubbornly high bp in phase 3 trial was published today ( Monday 30/06/2025 - 06:08 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Drug Lowers Stubbornly High BP in Phase 3 Trial )

Also on site :

• Kentucky congressman announces death of longtime staffer, campaign manager
• Camarillo man arrested after stolen camera reactivated and installed on the exterior of a home
• Patricia Heaton Mourns ‘The Middle’ Co-Star: ‘Our Hearts Are Broken’